BNGO vs ILMN
Bionano Genomics (BNGO) and Illumina (ILMN) are both key players in the genome analysis space, but their business models do not put them in direct competition with each other. While BNGO develops and markets a platform that gives researchers and clinicians the tools to enhance the search for diagnostics and therapeutics (a system called Saphyr), ILMN provides instruments and consumables used in genetic analysis. Both BNGO and ILMN sell to similar customers, i.e., research centers, government laboratories, pharmaceutical companies, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. ILMN is a substantially larger company, with over $3 billion in annual revenue and positive net income. BNGO is much smaller scale, with revenues around $10 million and still not profitable.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BNGO’s FA Score shows that 1 FA rating(s) are green whileILMN’s FA Score has 0 green FA rating(s).
- BNGO’s FA Score: 1 green, 4 red.
- ILMN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BNGO’s TA Score shows that 2 TA indicator(s) are bullish while ILMN’s TA Score has 4 bullish TA indicator(s).
- BNGO’s TA Score: 2 bullish, 7 bearish.
- ILMN’s TA Score: 4 bullish, 5 bearish.
Price Growth
BNGO (@Medical Specialties) experienced а -1.38% price change this week, while ILMN (@Medical Specialties) price change was -7.04% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.88%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was +7.26%.
Reported Earning Dates
BNGO is expected to report earnings on Nov 09, 2023.
ILMN is expected to report earnings on May 01, 2025.
Industries' Descriptions
@Medical Specialties (-0.88% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BNGO | ILMN | BNGO / ILMN | |
| Capitalization | 57.4M | 21.1B | 0% |
| EBITDA | -213.4M | -608M | 35% |
| Gain YTD | -71.105 | -7.057 | 1,008% |
| P/E Ratio | N/A | 49.50 | - |
| Revenue | 36.1M | 4.5B | 1% |
| Total Cash | 102M | 1.05B | 10% |
| Total Debt | 79.4M | 2.26B | 4% |
BNGO | ILMN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 25 Undervalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 97 | |
PRICE GROWTH RATING 1..100 | 98 | 60 | |
P/E GROWTH RATING 1..100 | 90 | 94 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BNGO's Valuation (25) in the Biotechnology industry is somewhat better than the same rating for ILMN (75). This means that BNGO’s stock grew somewhat faster than ILMN’s over the last 12 months.
BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ILMN (100). This means that BNGO’s stock grew similarly to ILMN’s over the last 12 months.
ILMN's SMR Rating (97) in the Biotechnology industry is in the same range as BNGO (99). This means that ILMN’s stock grew similarly to BNGO’s over the last 12 months.
ILMN's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for BNGO (98). This means that ILMN’s stock grew somewhat faster than BNGO’s over the last 12 months.
BNGO's P/E Growth Rating (90) in the Biotechnology industry is in the same range as ILMN (94). This means that BNGO’s stock grew similarly to ILMN’s over the last 12 months.
| BNGO | ILMN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 87% | 1 day ago 69% |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 70% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 80% |
| Advances ODDS (%) | N/A | 9 days ago 71% |
| Declines ODDS (%) | 8 days ago 89% | 1 day ago 80% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 76% |
BNGO and
Correlation & Price change
A.I.dvisor tells us that BNGO and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNGO and QDEL's prices will move in lockstep.
| Ticker / NAME | Correlation To BNGO | 1D Price Change % | ||
|---|---|---|---|---|
| BNGO | 100% | -5.66% | ||
| QDEL - BNGO | 31% Poorly correlated | +0.49% | ||
| CZMWY - BNGO | 31% Poorly correlated | +2.36% | ||
| ARAY - BNGO | 31% Poorly correlated | +6.39% | ||
| ILMN - BNGO | 31% Poorly correlated | -5.26% | ||
| CRL - BNGO | 31% Poorly correlated | +0.93% | ||
More | ||||
ILMN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.
| Ticker / NAME | Correlation To ILMN | 1D Price Change % | ||
|---|---|---|---|---|
| ILMN | 100% | -5.26% | ||
| RVTY - ILMN | 53% Loosely correlated | -0.43% | ||
| VCYT - ILMN | 49% Loosely correlated | -2.91% | ||
| BIO - ILMN | 48% Loosely correlated | -2.01% | ||
| A - ILMN | 46% Loosely correlated | -1.07% | ||
| PACB - ILMN | 45% Loosely correlated | -1.37% | ||
More | ||||